Q2 FY2026 EarningsFY26 Q2 beat consensus on the top line and EPS: revenue of $64.1M vs. $56.6M expected, and gross margin reached 83.0% vs. 80.4% expected. Heartflow revenue cases surged 74% YoY to 84,491, significantly driven by the rapid adoption of Heartflow Plaque Analysis following new CPT reimbursement coverage. While operating losses (EBIT) were wider than expected due to aggressive R&D and SG&A headcount expansion, a strong $2.3M interest income contribution narrowed the GAAP net loss to -$15.7M, beating the -$16.5M consensus.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: HeartFlow(HTFL) the Revenue is 64.08 M (+48.19%), Beat estimate;the EBIT is -7.924 M (+30.87%), Beat estimate;the EPS is -0.18 (+87.67%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.06B48.19%
0.06B30.98%
+0.01B17.21%
EBITExceed expectations
-0.01B30.87%
-0.01B13.13%
+0.01B44.00%
EPSExceed expectations
-0.1887.67%
-0.197586.47%
+0.01751.20%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf